Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Within the limitations of small sample size, there does not appear to be a benefit of probiotic therapy for portal pressure reduction in patients with compensated or early decompensated cirrhosis.
The reductions in endotoxin and aldosterone suggest possible beneficial effects of probiotics for this patient population.
The clinical significance of the small but unexpected increase in TNF-alfa is unclear.
see also:
Akkermansia muciniphila & Liver Fibrosis / Cirrhosis (Prevention)
[Lactibiane Tolerance & Liver Fibrosis / Cirrhosis](brain://DbUSfQCADke9T69b8mu16A/LactibianeToleranceLiverFibro…